50-112-8664

CD319 (CRACC) Monoclonal Antibody (162), PE, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 50-112-8664-Each-of-1 In Stock ₹ 28,836.00

50-112-8664 - Each of 1

₹ 28,836.00

In Stock

Quantity

1

Base Price: ₹ 28,836.00

GST (18%): ₹ 5,190.48

Total Price: ₹ 34,026.48

Antigen

CD319 (CRACC)

Classification

Monoclonal

Concentration

5 μL/Test

Formulation

PBS with 0.2% BSA and 0.09% sodium azide; pH 7.2

Gene Accession No.

Q9NQ25

Gene Symbols

SLAMF7

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

57823

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

162

Conjugate

PE

Gene

SLAMF7

Gene Alias

19A; 19A24; 19A24 protein; 4930560D03Rik; CD2 subset 1; CD2-like receptor activating cytotoxic cells; CD2-like receptor-activating cytotoxic cells; CD319; CRACC; CS1; Leukocyte cell-surface antigen; membrane protein FOAP-12; Novel Ly9; novel LY9 (lymphocyte antigen 9) like protein; protein 19A; RGD1560190; SLAM family member 7; SLAMF7; UNQ576/PRO1138

Host Species

Mouse

Quantity

100 Tests

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2b κ

Related Products

Img

Invitrogen

50-112-9269

--

Img

Invitrogen

50-117-71

--

Img

Invitrogen

17-336-942

--

Img

Invitrogen

50-112-8656

--

Img

Invitrogen

50-112-9126

--

Img

Invitrogen

17-307-942

--

Img

Invitrogen

50-113-0800

--

Img

Invitrogen

50-112-4893

--

Description

  • Description: The monoclonal antibody 162 recognizes CRACC (CD2 like receptor for activating cytotoxic cells) also known as CD319 and CS1
  • It is a member of the SLAM receptor family
  • CRACC is a 66kDa glycosylated transmembrane protein which contains a cytoplasmic ITSM domain (Immunoreceptor Tyrosine-based Switch Motif)
  • It is this domain, found in other proteins such as CD244 and NTB-A, that interacts with SH2 containing proteins such as SAP
  • Interestingly the ITSM domain in CRACC is SAP independent
  • Instead EAT-2 acts as the signaling molecule for CRACC
  • This has profound impact for patients with X-linked lymphoproliferative disease (contains a SAP mutation)
  • It should be noted that a splice variant has been reported which deletes the ITSM domain
  • Applications Reported: This 162 antibody has been reported for use in flow cytometric analysis
  • Applications Tested: This 162 antibody has been pre-titrated and tested by flow cytometric analysis of normal human peripheral blood cells
  • This can be used at 5 μL (1 μg) per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • Excitation: 488-561 nm; Emission: 578 nm; Laser: Blue Laser, Green Laser, Yellow-Green Laser
  • Filtration: 0.2 μm post-manufacturing filtered
  • SLAMF7 contains one Ig-like C2-type (immunoglobulin-like) domain
  • Isoform 1 mediates NK cell activation through a SAP-independent extracellular signal-regulated ERK-mediated pathway
  • It may play a role in lymphocyte adhesion
  • Isoform 3 does not mediate any activation
  • SAP can bind the cytoplasmic tail of isoform 1 when phosphorylated in the presence of Fyn (in vitro)
  • SLAMF7 is expressed in spleen, lymph node, peripheral blood leukocytes, bone marrow, small intestine, stomach, appendix, lung and trachea
  • Expression was detected in NK cells, activated B-cells, NK-cell line but not in promyelocytic, B-, or T-cell lines
  • The isoform 3 is expressed at much lower level than isoform 1
  • There are three named isoforms.